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Case-report
• 10-year-old child in follow-up for almost a decade at Ghent
University Hospital.
• During his fetal period, his mother suffered malignant
hypertension and had to continue her prescribed ACE-
inhibitors despite known teratogenic effects.
Background
Angiotensin-converting enzyme inhibitors (ACE-inhibitors) are among the most frequently prescribed antihypertensive drugs (1-4).
Ingestion during pregnancy has a known increased risk of fetopathy, with well-described congenital malformations (2,3,5,6). Until now,
little is known about the long-term outcome and the impact on a child’s life. (7,8) The objective of this case report is to analyze long term
outcome following prenatal exposure to ACE-inhibitors and describe the subsequent impact.
Discussion
Renal hypoplasia is well known in newborns prenatally exposed to ACE-inhibition, but there
is a gap in knowledge on other organs and long-termprognosis.
This case documents that other organs are equally involved, and that long-term
neurocognitive development is compromised in children having endured fetal exposure to
ACE-inhibitors.
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Ultrasound  of the kidney 
at one month old (right) showing a diameter of 6cm.
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• Born with hypocalvaria (i.e. incompletely formed skull bones) as
well as severe abnormalities of the central nervous system,
resulting in motor impairment (including a right-sided paresis
due to sequels of cortical haemorrhage)
as well as developmental delay.
• Initial need for dialysis, renal function recovered partially, but
caused the need for dialysis and kidney transplantation at the
age of 4-years without post-operative complications and without
further complications after discharge.
MRI of the brain at one month old, showing sequels
of haemorrhage shown in centrum semioval left to cortical left 
and in the right periventricular area. 
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